While the exact results varied depending on the trial, patients receiving Enhertu generally report fewer severe side effects compared to traditional chemotherapy “In clinical trials, tumors with ...

DESTINY-Breast06 trial showed Enhertu reduced disease progression or death by 36% compared to chemotherapy. Key side effects of Enhertu include myelosuppression, gastrointestinal issues, and ...

Enhertu is a combination of a chemotherapy drug ... allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug ...

Specifically, Enhertu (trastuzumab deruxtecan ... Offsetting the increased efficacy is a risk of severe side effects, including interstitial lung disease (ILD), that may be more significant ...

Enhertu improved overall survival versus chemotherapy in HER2-positive metastatic gastric cancer, prompting an interim ...

At ASCO, commentators said the efficacy of the ADC would need to be balanced with its potential to cause side effects, as Enhertu can lead to more serious toxicities – such as interstitial lung ...

Enhertu was also approved for HER2-positive ... Participants treated with Datroway also saw fewer severe side effects: the rate of severe adverse events was about 21% in the Datroway group and ...